Qualys director sells 940 shares in planned trades
QUALYS, INC. director Jeffrey P. Hank reported open-market sales of company common stock across two days.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
QUALYS, INC. director Jeffrey P. Hank reported open-market sales of company common stock across two days. He sold 470 shares at $108.88 per share on June 11, 2026, and another 470 shares at $110.75 per share on June 12, 2026.
After these transactions, he directly holds 15,576 shares of Qualys common stock. According to a footnote, the sale transaction reported in this Form 4 was effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 470 | $110.75 | $52K |
| Sale | Common Stock | 470 | $108.88 | $51K |
Footnotes (1)
- F1. This sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2026.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Qualys (QLYS) director Jeffrey P. Hank report?
Were Jeffrey P. Hank’s Qualys (QLYS) stock sales under a Rule 10b5-1 plan?
What type of security did Jeffrey P. Hank trade in the Qualys (QLYS) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.